Alpha-theta border EEG abnormalities in preclinical Huntington's disease

Journal of the Neurological Sciences

Volumn 344, Issue 1-2, 2014, Pages 114-120

  Ponomareva, Natalya ^a   Klyushnikov, Sergey ^a   Abramycheva, Natalya ^a   Malina, Daria ^a   Scheglova, Nadejda ^a   Fokin, Vitaly ^a   Ivanova Smolenskaia, Irina ^a   Illarioshkin, Sergey ^a  

^a RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

CAG repeats; Cognitive functions; EEG; HTT gene; Huntington's disease; Preclinical stage

Indexed keywords

HUNTINGTIN; HTT PROTEIN, HUMAN; NERVE PROTEIN;

ADULT; ALPHA RHYTHM; ARTICLE; CAG REPEAT; CONTROLLED STUDY; EEG ABNORMALITY; FEMALE; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; MALE; PRIORITY JOURNAL; RUSSIAN (PEOPLE); RUSSIAN FEDERATION; THETA RHYTHM; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; ELECTROENCEPHALOGRAPHY; GENETICS; MUTATION; NEUROPSYCHOLOGICAL TEST; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICS; TRINUCLEOTIDE REPEAT;

ADULT; ALPHA RHYTHM; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MUTATION; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; THETA RHYTHM; TRINUCLEOTIDE REPEATS;

EID: 84906793890     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.06.035     Document Type: Article

References (66)

1. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971 983
2. S.C. Warby, H. Visscher, J.A. Collins, C.N. Doty, C. Carter, and S.L. Butland et al. HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia Eur J Hum Genet 19 2011 561 566
3. O.C. Stine, N. Pleasant, M.L. Franz, M.H. Abbott, S.E. Folstein, and C.A. Ross Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15 Hum Mol Genet 2 1993 1547 1549
4. S.N. Illarioshkin, S. Igarashi, O. Onodera, E.D. Markova, N.N. Nikolskaya, and H. Tanaka et al. Trinucleotide repeat length and rate of progression of Huntington's disease Ann Neurol 36 1994 630 635
5. D.C. Rubinsztein, J. Leggo, R. Coles, E. Almqvist, V. Biancalana, and J.J. Cassiman et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats Am J Hum Genet 59 1996 16 22
6. S. Li, and X.J. Li Multiple pathways contribute to the pathogenesis of Huntington disease Mol Neurodegener 1 2006 19 10.1186/1750-1326-1-19
7. H.D. Rosas, D.H. Salat, S.Y. Lee, A.K. Zaleta, V. Pappu, and B. Fischl et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity Brain 131 Pt 4 2008 1057 1068
8. I. Bohanna, N. Georgiou-Karistianis, A.J. Hannan, and G.F. Egan Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease Brain Res Rev 58 2008 209 225
9. A. Feigin, C. Tang, Y. Ma, P. Mattis, D. Zgaljardic, and M. Guttman et al. Thalamic metabolism and symptom onset in preclinical Huntington's disease Brain 130 2007 2858 2867
10. Z.A. Suslina Neurology at the border of centuries: achievements and prospects Vestn Ross Akad Med Nauk 8 2012 57 65
11. M.S. Levine, C. Cepeda, M.A. Hickey, S.M. Fleming, and M.F. Chesselet Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect Trends Neurosci 27 2004 691 697
12. E.H. Aylward, A.M. Codori, P.E. Barta, G.D. Pearlson, G.J. Harris, and J. Brandt Basal ganglia volume and proximity to onset in presymptomatic Huntington disease Arch Neurol 53 1996 1293 1296
13. A. Antonini, K.L. Leenders, and D. Eidelberg [11C]raclopride-PET studies of the Huntington's disease rate of progression: relevance of the trinucleotide repeat length Ann Neurol 43 1998 253 255
14. E.H. Aylward, A.M. Codori, A. Rosenblatt, M. Sherr, J. Brandt, and O.C. Stine et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease Mov Disord 15 2000 552 560
15. J.S. Paulsen, J.L. Zimbelman, S.C. Hinton, D.R. Langbehn, C.L. Leveroni, and M.L. Benjamin et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease AJNR Am J Neuroradiol 25 2004 1715 1721
16. L. Nguyen, J.L. Bradshaw, Julie C. Stout, R. Croft, and N. Georgiou-Karistianis Electrophysiological measures as potential biomarkers in Huntington's disease: review and future directions Brain Res Rev 64 2010 177 194
17. C. Beste, A.K. Stock, V. Ness, R. Hoffmann, C. Lukas, and C. Saft A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data Sci Rep 3 2013 1797 10.1038/srep01797
18. W. Klimesch EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis Brain Res Brain Res Rev 29 1999 169 195
19. C.J. Stam, Y. van der Made, Y.A. Pijnenburg, and P. Scheltens EEG synchronization in mild cognitive impairment and Alzheimer's disease Acta Neurol Scand 108 2003 90 96
20. K. Jann, T. Dierks, C. Boesch, M. Kottlow, W. Strik, and T. Koenig BOLD correlates of EEG alpha phase-locking and the fMRI default mode network Neuroimage 45 2009 903 916
21. W. Klimesch α-band oscillations, attention, and controlled access to stored information Trends Cogn Sci 16 2012 606 617
22. S.P. Fisher, S.W. Black, M.D. Schwartz, A.J. Wilk, T.M. Chen, and W.U. Lincoln et al. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease Brain 136 Pt 7 2013 2159 2172
23. S.K. Sishta, A. Troupe, K.S. Marszalek, and L.M. Kremer Huntington's chorea: an electroencephalographic and psychometric study Electroencephalogr Clin Neurophysiol 36 4 1974 387 393
24. F.W. Bylsma, C.E. Peyser, S.E. Folstein, M.F. Folstein, C. Ross, and J. Brandt EEG power spectra in Huntington's disease: clinical and neuropsychological correlates Neuropsychologia 32 1994 137 150
25. R. Bellotti, F. De Carlo, R. Massafra, M. de Tommaso, and V. Sciruicchio Topographic classification of EEG patterns in Huntington's disease Neurol Clin Neurophysiol 2004 2004 37
26. A. Painold, P. Anderer, A.K. Holl, M. Letmaier, G.M. Saletu-Zyhlarz, and B. Saletu et al. Comparative EEG mapping studies in Huntington's disease patients and controls J Neural Transm 117 2010 1307 1318
27. A. Painold, P. Anderer, A.K. Holl, M. Letmaier, G.M. Saletu-Zyhlarz, and B. Saletu et al. EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's disease J Neurol 258 5 2011 840 854
28. A. Hunter, Y. Bordelon, I. Cook, and A. Leuchter QEEG measures in Huntington's disease: a pilot study PLoS Curr 2 2010 RRN1192 10.1371/currents.RRN1192
29. L.J. Streletz, P.F. Reyes, M. Zalewska, L. Katz, and R.G. Fariello Computer analysis of EEG activity in dementia of the Alzheimer's type and Huntington's disease Neurobiol Aging 11 1990 15 20
30. M. de Tommaso, F. De Carlo, O. Difruscolo, R. Massafra, V. Sciruicchio, and R. Bellotti Detection of subclinical brain electrical activity changes in Huntington's disease using artificial neural networks Clin Neurophysiol 114 2003 1237 1245
31. K. Van der Hiele, C.K. Jurgens, A.A. Vein, R.H. Reijntjes, M.W. Witjes-Ane, and R.A. Roos et al. Memory activation reveals abnormal EEG in preclinical Huntington's disease Mov Disord 22 2007 690 695
32. C. Anderson, and J.A. Horne Presleep relaxed 7-8 Hz EEG from left frontal region: marker of localised neuropsychological performance? Physiol Behav 81 2004 657 664
33. C. Babiloni, G. Binetti, E. Cassetta, G. Dal Forno, C. Del Percio, and F. Ferreri et al. Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: a multicenter study Clin Neurophysiol 117 2006 252 268
34. O.M. Razumnikova, I.V. Tarasova, and N.V. Vol'f Characteristics of cortical activity in persons with high and low verbal creativity: analysis of alpha1,2 rhythms Zh Vyssh Nerv Deiat Im I P Pavlova 59 2009 581 586
35. L. Michels, K. Bucher, R. Lüchinger, P. Klaver, E. Martin, and D. Jeanmonod et al. Simultaneous EEG-fMRI during a working memory task: modulations in low and high frequency bands PLoS One 5 2010 e10298 10.1371/journal.pone. 0010298
36. D.V. Moretti, O. Zanetti, G. Binetti, and G.B. Frisoni Quantitative EEG markers in mild cognitive impairment: degenerative versus vascular brain impairment Int J Alzheimers Dis 2012 2012 917537 10.1155/2012/917537
37. S.J. Tabrizi, R. Reilmann, R.A. Roos, A. Durr, B. Leavitt, and G. Owen et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data Lancet Neurol 11 1 2012 42 53
38. Huntington Study Group Unified Huntington's disease rating scale: reliability and consistency Mov Disord 11 1996 136 142
39. M. Folstein, S. Folstein, and P. McHugh 'Mini-Mental State': a practical method for grading the cognitive state of patients for clinician J Psychiatr Res 12 1975 189 198
40. V. Milstein, J.G. Small, and I.F. Small The subtraction of serial sevens test in psychiatric patients Arch Gen Psychiatry 26 1972 439 441
41. A.L. Benton, and K.D. Hamsher Multilingual aphasia examination 1989 AJA Associates Iowa City, IA
42. C.D. Spielberger Manual for the State-Trait Anxiety Inventory: STAI (Form Y) 1983 Consulting Psychologists Press Palo Alto, CA
43. A.K. Ho, B.J. Sahakian, T.W. Robbins, R.A. Barker, A.E. Rosser, and J.R. Hodges Verbal fluency in Huntington's disease: a longitudinal analysis of phonemic and semantic clustering and switching Neuropsychologia 40 8 2002 1277 1284
44. D.L. Harrington, M.M. Smith, Y. Zhang, N.E. Carlozzi, J.S. Paulsen PREDICT-HD Investigators of the Huntington Study Group Cognitive domains that predict time to diagnosis in prodromal Huntington disease J Neurol Neurosurg Psychiatry 83 6 2012 612 619
45. M. Versavel, J.P. Leonard, and W.M. Herrmann Standard operating procedure for registration and computer-supported evaluation of pharmaco-EEG data Neuropsychobiology 32 1995 166 170
46. M. Jobert, F.J. Wilson, T. Roth, G.S. Ruigt, P. Anderer, and W.H. Drinkenburg et al. IPEG Pharmaco-EEG Guidelines Committee: guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG) Neuropsychobiology 67 2013 127 167
47. L. De Gennaro, M. Ferrara, F. Vecchio, G. Curcio, and M. Bertini An electroencephalographic fingerprint of human sleep Neuroimage 26 1 2005 114 122
48. M.H. Silber, S. Ancoli-Israel, M.H. Bonnet, S. Chokroverty, M.M. Grigg-Damberger, and M. Hirshkowitz et al. The visual scoring of sleep in adults J Clin Sleep Med 3 2 2007 121 131
49. E.R. John, H. Ahn, L.S. Prichep, M. Trepetin, D. Brown, and H. Kaye Developmental equations for the electroencephalogram Science 210 1980 1255 1258
50. N.V. Ponomareva, N.D. Selesneva, and G.A. Jarikov EEG alterations in subjects at high familial risk for Alzheimer's disease Neuropsychobiology 48 2003 152 159
51. N.V. Ponomareva, G.I. Korovaitseva, and E.I. Rogaev EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease Neurobiol Aging 29 2008 819 827
52. S.E. Andrew, Y.P. Goldberg, J. Theilmann, J. Zeisler, and M.R. Hayden A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing Hum Mol Genet 3 1994 65 67
53. O. Jensen, and C.D. Tesche Frontal theta activity in humans increases with memory load in a working memory task Eur J Neurosci 15 2002 1395 1399
54. Y.F. Low, and D.J. Strauss EEG phase reset due to auditory attention: an inverse time-scale approach Physiol Meas 30 2009 821 832
55. S.D. Slotnick, L.R. Moo, M.A. Kraut, R.P. Lesser, and J. Hart Interactions between thalamic and cortical rhythms during semantic memory recall in human Proc Natl Acad Sci U S A 99 2002 6440 6443
56. N.E. Crone, D.L. Miglioretti, B. Gordon, J.M. Sieracki, M.T. Wilson, and S. Uematsu et al. Functional mapping of human sensorimotor cortex with electrocorticographic spectral analysis. I. Alpha and beta event-related desynchronization Brain 121 1998 2271 2299
57. T.M. Sokhadze, R.L. Cannon, and D.L. Trudeau EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research Appl Psychophysiol Biofeedback 33 2008 1 28
58. G. Gonzalez-Burgos, and D.A. Lewis GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia Schizophr Bull 34 2008 944 961
59. J. Spampanato, X. Gu, X.W. Yang, and I. Mody Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease Neuroscience 157 2008 606 620
60. H.D. Rosas, A.S. Feigin, and S.M. Hersch Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease NeuroRx 1 2004 263 272
61. B. Porjesz, and H. Begleiter Alcoholism and human electrophysiology Alcohol Res Health 27 2 2003 153 160
62. C. Beste, C. Saft, J. Yordanova, J. Andrich, R. Gold, and M. Falkenstein et al. Functional compensation or pathology in cortico-subcortical interactions in preclinical Huntington's disease? Neuropsychologia 45 13 2007 2922 2930
63. C. Beste, V. Nessa, M. Falkenstein, and C. Saft On the role of fronto-striatal neural synchronization processes for response inhibition - evidence from ERP phase-synchronization analyses in pre-manifest Huntington's disease gene mutation carriers Neuropsychologia 49 12 2011 3484 3493
64. C. Beste, V. Ness, C. Lukas, R. Hoffmann, S. Stüwe, and M. Falkenstein et al. Mechanisms mediating parallel action monitoring in fronto-striatal circuits Neuroimage 62 1 2012 137 146
65. A.E. Molero, S. Gokhan, S. Gonzalez, J.L. Feig, L.C. Alexandre, and M.F. Mehler Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease Proc Natl Acad Sci U S A 106 2009 21900 21905
66. P.C. Nopoulos, E.H. Aylward, C.A. Ross, J.A. Mills, D.R. Langbehn, and H.J. Johnson et al. Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment Brain 134 Pt 1 2011 137 142